The Washington Post reports:
Pfizer and its German partner BioNTech are expected to seek authorization for their coronavirus vaccine booster shot for anyone 18 and older, a move that could increase booster rates at a critical moment in the pandemic, according to three officials familiar with the situation.
The request, which may be filed as soon as this week, is likely to win the backing of the Food and Drug Administration, said the individuals, who spoke on the condition of anonymity because they were not authorized to discuss the issue.
That would essentially fulfill the Biden administration’s booster-for-all-adults goal, announced last August amid concerns about waning vaccine protection.
Read the full article.
Pfizer-BioNTech expected to seek authorization for coronavirus booster for people 18 and older https://t.co/v38mXP8RkO
— The Washington Post (@washingtonpost) November 8, 2021